000 | 01706 a2200529 4500 | ||
---|---|---|---|
005 | 20250515153958.0 | ||
264 | 0 | _c20090901 | |
008 | 200909s 0 0 eng d | ||
022 | _a1536-4844 | ||
024 | 7 |
_a10.1002/ibd.20859 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRuuska, T | |
245 | 0 | 0 |
_aGranulocyte-monocyte adsorptive apheresis in pediatric inflammatory bowel disease: results, practical issues, safety, and future perspectives. _h[electronic resource] |
260 |
_bInflammatory bowel diseases _cJul 2009 |
||
300 |
_a1049-54 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 |
_aAdrenal Cortex Hormones _xtherapeutic use |
650 | 0 | 4 |
_aBlood Component Removal _xadverse effects |
650 | 0 | 4 | _aChild |
650 | 0 | 4 |
_aColitis, Ulcerative _xdrug therapy |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 |
_aCrohn Disease _xdrug therapy |
650 | 0 | 4 | _aDrug Resistance |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aGranulocytes |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMonocytes |
650 | 0 | 4 | _aPatient Compliance |
650 | 0 | 4 | _aRecurrence |
650 | 0 | 4 | _aRemission Induction |
650 | 0 | 4 | _aRetrospective Studies |
700 | 1 | _aWewer, V | |
700 | 1 | _aLindgren, F | |
700 | 1 | _aMalmborg, P | |
700 | 1 | _aLindquist, M | |
700 | 1 | _aMarthinsen, L | |
700 | 1 | _aBrowaldh, L | |
700 | 1 | _aCasswall, T | |
700 | 1 | _aKalliomäki, M | |
700 | 1 | _aGrönlund, J | |
773 | 0 |
_tInflammatory bowel diseases _gvol. 15 _gno. 7 _gp. 1049-54 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/ibd.20859 _zAvailable from publisher's website |
999 |
_c18585790 _d18585790 |